ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CAPR Capricor Therapeutics Inc

11.68
-1.20 (-9.32%)
After Hours
Last Updated: 23:11:00
Delayed by 15 minutes

Capricor Therapeutics Financial Summary

The current CAPR market cap is 531.09M. The company's latest EPS is USD -0.4902 and P/E is -23.66.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 6.19M12.09M4.91M3.97M2.26M
Operating Income -8.57M-1.28M-10.27M-11.59M-13.01M
Net Income -6.39M-763k-9.79M-11M-12.56M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.01M310k245k2.55M25.18M
Operating Income -7.73M-13.69M-20.94M-29.7M-24.08M
Net Income -7.64M-13.66M-20.02M-29.02M-22.29M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 37.15M58.73M49.44M38.28M92.95M
Total Liabilities 38.94M36.13M31.01M26.78M24.69M
Total Equity -1.79M22.6M18.44M11.5M68.27M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 11.11M34.62M41.33M50.1M58.73M
Total Liabilities 4.28M6.42M9.96M38.31M36.13M
Total Equity 6.84M28.2M31.37M11.79M22.6M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -14M-25.6M-1.27M-13.56M-25.2M
Investing 10.97M5.11M-9.5M5.19M7.2M
Financing 2.41M25.58M2.29M4.36M71.68M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -6.82M-10.05M-16.81M4.92M-25.6M
Investing -3M5.44M-1.2M-35.07M5.11M
Financing 9.18M33.38M20.23M4.87M25.58M
Market Cap 531.09M
Price to Earnings Ratio -23.66
Price to Sales Ratio 20.95
Price to Cash Ratio 35.89
Price to Book Ratio 23.34
Dividend Yield -

Share Statistics

Shares Outstanding 45.47M
Average Volume (1 week) 973.14k
Average Volume (1 Month) 1.43M
52 Week Change 82.50%
52 Week High 23.40
52 Week Low 3.52
Spread (Intraday) 0.13 (1.11%)

Company Info

Company Name Capricor Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.capricor.com
Industry pharmaceutical preparations (2834)